Compare stocks

Alcon Inc. is a global company specializing in eye care products and medical devices, serving the healthcare sector. The company focuses on two main divisions: Surgical and Vision Care. Its Surgical segment offers ophthalmic products such as cataract, retinal, and refractive surgery equipment, while the Vision Care segment provides contact lenses and lens care products. Headquartered in Geneva, Switzerland, Alcon was founded in 1945 as a small ophthalmic shop in Texas and has since expanded its footprint internationally. Alcon benefits from its extensive research and development capabilities, underpinned by a robust portfolio of market-driven innovations aiming to address unmet eye care needs globally.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.